Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond
ME Cabanillas, M Ryder, C Jimenez - Endocrine reviews, 2019 - academic.oup.com
The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and beyond
ME Cabanillas, M Ryder… - Endocrine …, 2019 - mdanderson.elsevierpure.com
The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
[HTML][HTML] Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
ME Cabanillas, M Ryder, C Jimenez - Endocrine Reviews, 2019 - ncbi.nlm.nih.gov
The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
ME Cabanillas, M Ryder, C Jimenez - Endocrine Reviews, 2019 - europepmc.org
The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
ME Cabanillas, M Ryder, C Jimenez - 2019 - academic.oup.com
The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
ME Cabanillas, M Ryder, C Jimenez - Endocrine Reviews, 2019 - search.ebscohost.com
The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
ME Cabanillas, M Ryder, C Jimenez - Endocrine Reviews, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The treatment of advanced thyroid cancer has
undergone rapid evolution in the last decade, with multiple kinase inhibitor drug approvals …
undergone rapid evolution in the last decade, with multiple kinase inhibitor drug approvals …
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
ME Cabanillas, M Ryder, C Jimenez - Endocrine Reviews, 2019 - go.gale.com
The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
ME Cabanillas, M Ryder, C Jimenez - Endocrine reviews, 2019 - pubmed.ncbi.nlm.nih.gov
The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
ME Cabanillas, M Ryder, C Jimenez - Endocrine Reviews, 2019 - europepmc.org
The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …